Identifies repurposed generic drugs that may be effective treatment options for a patient's cancer.
Consented intake · your records travel with you · nothing moves without your sign-off
Reboot Rx focuses on repurposed generic drugs as cancer treatment options. Through biomarker-drug matching based on a patient's disease profile, it helps identify the options with the most likely effective response, including existing generic medicines being applied to cancer. It is for patients who want their treatment search to include well-known drugs used in new ways.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Reboot Rx (repurposed generic drugs) handles billing.
We don't have confirmed insurance details for Reboot Rx (repurposed generic drugs) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Reboot's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Provide a trusted medical context for personalized experiments; contribute to research that will benefit others and hope that new treatments will be identified in time that may help me.
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.